Total shoulder arthroplasty (TSA) has been shown to reduce pain and to improve function and patient satisfaction. However, preoperative factors predicting poor outcomes remain relatively unexplored. With the increasing popularity of shoulder arthroplasty and a growing aging population that desires to remain active, the volume of TSAs increased by 534% from 2000 to 2010 in the United States.[@bib24] As surgeons\' experience with both anatomic TSA and reverse TSA (RTSA) expands to include predictable improvements in range of motion and overall quality of life, surgical indications for shoulder arthroplasty have shifted from primarily glenohumeral osteoarthritis (OA) to now include rotator cuff arthropathy (CA), irreparable rotator cuff tears, and proximal humerus fractures.[@bib35] These expanded surgical indications along with an increased number of insured patients since the advent of the Affordable Care Act have contributed to a higher prevalence of arthroplasty patients with preoperative risk factors for costly care under hospital quality metrics.[@bib27] With the shift toward delivery of cost-efficient care through bundled payments and outcomes-based reimbursements, it is important for health care providers to consider risk factors that predict readmissions and postoperative complications.

The expanding surgical indications for TSA point to the growing diverse population of patients, pathologic processes, and comorbidities that uniquely affect recovery. For example, patients requiring TSA for revision as opposed to OA or CA have significant differences in inpatient hospital outcomes and risks for surgical site infection (SSI).[@bib32] Prior studies have suggested that complication rates are higher in patients undergoing revision compared with primary TSA as previous soft tissue disruption may be linked to poor arthroplasty outcomes, such as instability, infection, and nonunion after fracture.[@bib3], [@bib32] Even in comparing patients presenting for revision TSA, the cause of revision, whether component loosening or pain, may predict better outcomes than in revisions performed for infection. The increasing rate of shoulder arthroplasty procedures will increase the need for revision surgery, and thus it is even more important to understand factors that contribute to poor outcomes.

Health care economics prioritizes patient satisfaction with cost-effective care. The literature is still unclear about the role of rotator cuff disease as it compares with arthroplasty outcomes for OA and proximal humerus fractures. In assessing preoperative risk factors and hospital course, the role of primary OA, CA, and fracture as modifiers to the postoperative TSA rehabilitation protocol is unclear.[@bib26] Studies have shown that readmission rates for pulmonary embolism (PE) after discharge for TSA are comparable to those after hip arthroplasty.[@bib9], [@bib31], [@bib38] Comparison of length of stay, discharge destination, readmission, infection, and postoperative thrombosis and transfusion rates between patients is important, especially for elderly patients who may benefit from early active rehabilitation and restoration of autonomy as quickly as possible. Moreover, identifying differences in outcomes between surgical indications may minimize the potential for future revision surgery in patients who may benefit from nonoperative treatment.

With the Centers for Medicare and Medicaid Services and Hospital Readmissions Reduction Program creating penalties for postoperative readmission, providers should be aware of patient comorbidities and indications that predict adverse outcomes. Many patients with newly acquired access to health care have increased risk factors for poor outcomes because of the relatively high rates of smoking status, pulmonary disease, and vascular disease.[@bib8] By understanding the role of surgical indications in postoperative outcomes, providers can better stratify and plan for the preoperative management and prevention of complications in at-risk patients that would fall outside a bundled payment model. In identifying OA, CA, fracture, and revision surgery as independent risk factors for increased hospital stay and short-interval postoperative complications, providers can better educate and inform patients on expectations of outcomes and time to discharge according to the primary diagnosis.

Methods {#sec1}
=======

All TSAs from 2014 to 2016 were queried from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database. The NSQIP database includes deidentified perioperative data and patient information from \>600 hospitals nationwide ranging from small community hospitals to large tertiary academic centers. Clinical information is gathered by trained data reviewers prospectively collecting perioperative information on site through outpatient clinic visits, inpatient provider notes, and direct interviews.[@bib16] During the years 2014-2016, there were 274 collected variables identified for surgical patients; these included demographics, elective status, discharge destination, preoperative laboratory values, operative time, intraoperative complications, and 30-day postoperative complication and readmission rates.

All surgical patients who underwent primary TSAs from 2014 to 2016 with preoperative OA, CA, and proximal humerus fractures as indications for operation were identified and selected with *International Classification of Diseases* codes and *Current Procedural Terminology* (CPT) code 23472, which included both anatomic TSAs and RTSAs. Revision TSA cases involving either the humeral or glenoid component were identified with CPT codes 23473 and 23474. Etiologic factors for revision TSA were identified through *International Classification of Diseases* codes and included dislocation, loosening, infection, fractures, stiffness, rotator cuff disease, and pain. Age, sex, body mass index (BMI), diabetes status, smoking status, steroid use, American Society of Anesthesiologists (ASA) class, operation time, and elective surgery status were compared to assess baseline characteristics.[@bib20], [@bib22] Patients with routine intake of oral or parenteral corticosteroids or immunosuppressant medications within 30 days before surgery were categorized into the steroid group, whereas patients who smoked only cigarettes at any point within the past year before surgery were part of the smoking cohort.

Short-interval postoperative complications, including dislocation, readmission rate, nonroutine discharge, return to the operating room (OR), SSI, PE, deep venous thrombosis (DVT), bleeding requiring red blood cell transfusion, pneumonia, renal insufficiency, cardiac arrest, myocardial infarction, and urinary tract infection, were compared using bivariate and multivariate binary logistic regression. Discharge destination was dichotomized to routine (home) or nonroutine, which included rehabilitation and other care facilities. Reasons for readmission within 30 days of surgery included dislocation, infection, bleeding, pain, thrombosis, pneumonia, urinary tract infection, and cardiac complications. In the cohort of patients who were readmitted, bivariate logistic regression analysis was used to compare surgical indication and reason for readmission.

Multivariate binary logistic regression analyses were conducted to determine whether surgical indications of OA, CA, fracture, and revision were independent risk factors for postoperative complications. Regressions were adjusted for age, sex, elective status, BMI, diabetes status, smoking status, and steroid use and reported as odds ratios in relation to the 95% confidence interval. Postoperative time to discharge between surgical groups was analyzed by univariate analysis of variance with Tukey test for multiple comparisons. Statistical significance was defined as *P* \< .05 using SPSS software version 23.0 (IBM Corp., Armonk, NY, USA).

Results {#sec2}
=======

From 2014 to 2016, a total of 8614 patients undergoing TSAs were included in the study, including OA in 76% (n = 6570), CA in 8.40% (n = 725), fracture in 7.50% (n = 646), and revision in 7.80% (n = 673; [Table I](#tbl1){ref-type="table"}). Compared with OA, CA patients were more likely to be older (70.60 vs. 68.60 years), to be ASA class ≥3, to undergo shorter operative times, and to be diabetic (all *P* values \< .004; [Table II](#tbl2){ref-type="table"}). Compared with both OA and CA, fracture patients were more likely to be older and female, to be smokers, to be ASA class ≥3, to undergo longer operative times, to be diabetic, and not to have elective surgery (all *P* \< .024). Patients undergoing revision TSA were more likely to be younger, to have lower average BMI, to be smokers, to be ASA class ≥3, to have longer operative times, to be diabetic, and not to have elective surgery (all *P* \< .013) compared with patients undergoing primary TSA for OA and CA. Patients undergoing primary TSA for fracture were more likely to be older, female, ASA class ≥3, and diabetic and not to have elective surgery (all *P* \< .05) compared with revision patients. There was no difference in steroid use between the various surgical indication groups.Table IPatients\' demographic characteristics and comorbidity burdenBaseline characteristicsOA (n = 6570)CA (n = 725)Fracture (n = 646)Revision (n = 673)Patients768.407.507.80Average age (yr)68.6070.6072.4067.10Female sex53558156Average BMI, kg/m^2^31.2031.1031.4030.60Smoking9.8011.9012.8016.60Steroid or immunosuppressant use4.405.904.304.90ASA class2.502.602.702.60Operation time (min)11095.50129128Diabetes status16.6019.7025.2020.60Not elective0.701.3027.204.70[^1][^2]Table IIComparison of baseline characteristics between all surgical groups and associated *P* valuesBaseline characteristicsComparison of surgical indicationOA vs. fractureCA vs. fractureCA vs. OAOA/CA vs. revisionFracture vs. revisionFracture vs. OA/CA*P* valueAverage age**\<.001.002\<.001\<.001\<.001\<.001**Female sex**\<.001\<.001**.276.148**\<.001\<.001**Average BMI.070.929.159**.006**.755.100Smoking**.015**.579.082**\<.001**.053**.024**Steroid or immunosuppressant use.925.185.064.688.623.788ASA class ≥3**\<.001\<.001.004\<.001.002\<.001**Operation time (min)**\<.001\<.001\<.001\<.001**.629**\<.001**Diabetes status**\<.001.015.032.013.048\<.001**Not elective**\<.001\<.001**.085**\<.001\<.001\<.001**[^3][^4]

After controlling for age, sex, BMI, smoking, steroid use, ASA class, diabetes, and elective status in adjusted multivariate logistic regression analysis, CA patients were more likely to have postoperative SSI and DVT compared with OA patients (*P* = .007, .001; [Table III](#tbl3){ref-type="table"}). Compared with OA and CA patients, fracture patients were at a greater risk for readmission, postoperative dislocation, nonroutine discharge, return to the OR, SSI, PE, and postoperative bleeding requiring transfusion (*P* \< .022; [Table IV](#tbl4){ref-type="table"}, [Table V](#tbl5){ref-type="table"}, [Table VI](#tbl6){ref-type="table"}). Patients undergoing revision TSA were at a greater risk for readmission, postoperative dislocation, return to the OR, SSI, DVT, and postoperative bleeding requiring transfusion compared with primary OA and CA patients (*P* \< .013; [Table VII](#tbl7){ref-type="table"}). Compared with revision, fracture patients were at a greater risk for nonroutine discharge and postoperative bleeding requiring transfusion, but no statistically significant difference was seen in readmission, dislocation, SSI, or DVT rates ([Table VIII](#tbl8){ref-type="table"}).Table IIIBivariate and multivariate analysis of postoperative complications between CA and OACAOABivariate analysisMultivariate analysis(n = 725), %(n = 6570), %Odds ratio*P* valueOdds ratio*P* valueReadmission3.592.361.538 (1.008-2.346).0461.420 (0.929-2.172).106Postoperative dislocation0.550.461.209 (0.425-3.443).7221.283 (0.448-3.670).642Nonroutine discharge11.319.191.239 (0.967-1.586).0901.042 (0.802-1.353).758Return to OR1.381.051.357 (0.695-2.650).3711.373 (0.700-2.693).356Postoperative SSI0.830.263.217 (1.264-8.185).0143.696 (1.432-9.541)**.007**Postoperative PE0.550.272.019 (0.682-5.983).2051.891 (0.635-5.630).253Postoperative DVT0.970.214.565 (1.837-11.348).0014.533 (1.812-11.342)**.001**Postoperative bleeding requiring transfusion2.341.601.478 (0.880-2.482).1391.288 (0.763-2.173).343Postoperative pneumonia0.550.411.344 (0.469-3.853).5821.252 (0.433-3.618).678Postoperative renal insufficiency0.140.081.814 (0.212-15.544).5871.441 (0.165-12.570).741Postoperative cardiac arrest0.140.06N/A.992N/A.992Postoperative myocardial infarction0.410.172.478 (0.690-8.901).1642.035 (0.561-7.387).280Postoperative urinary tract infection0.550.521.066 (0.377-3.014).9030.940 (0.331-2.667).907[^5][^6]Table IVBivariate and multivariate analysis of postoperative complications between fracture and OA/CAFractureOA/CABivariate analysisMultivariate analysis(n = 646), %(n = 7295), %Odds ratio*P* valueOdds ratio*P* valueReadmission6.812.482.871 (2.044-4.033)\<.0012.335 (1.569-3.475)**\<.001**Postoperative dislocation2.010.474.386 (2.303-8.353)\<.0014.991 (2.398-10.386)**\<.001**Nonroutine discharge35.459.405.360 (4.479-6.414)\<.0012.494 (1.991-3.124)**\<.001**Return to OR2.791.062.687 (1.598-4.517)\<.0012.571 (1.409-4.692)**.002**Postoperative SSI0.620.321.970 (0.679-5.714).2123.736 (1.246-11.201)**.019**Postoperative PE0.930.303.099 (1.252-7.671).0143.135 (1.180-8.328)**.022**Postoperative DVT0.620.292.158 (0.739-6.306).1601.636 (0.435-6.154).467Postoperative bleeding requiring transfusion14.551.6710.012 (7.548-13.282)\<.0014.847 (3.437-6.835)**\<.001**Postoperative pneumonia0.930.422.197 (0.913-5.285).0790.716 (0.219-2.334).579Postoperative renal insufficiency0.310.083.773 (0.760-18.730).1042.103 (0.286-15.484).466Postoperative cardiac arrest0.310.052.826 (0.315-25.321).3530.618 (0.025-15.454).770Postoperative myocardial infarction0.620.193.240 (1.063-9.873).0391.224 (0.276-5.418).790Postoperative urinary tract infection1.860.523.615 (1.879-6.952)\<.0011.564 (0.664-3.681).306[^7][^8]Table VBivariate and multivariate analysis of postoperative complications between OA and fractureOAFractureBivariate analysisMultivariate analysis(n = 6570), %(n = 646), %Odds ratio*P* valueOdds ratio*P* valueReadmission2.366.810.331 (0.234-0.467)\<.0010.433 (0.286-0.657)**\<.001**Postoperative dislocation0.462.010.223 (0.116-0.430)\<.0010.202 (0.091-0.445)**\<.001**Nonroutine discharge9.1935.450.182 (0.152-0.219)\<.0010.378 (0.300-0.476)**\<.001**Return to OR1.052.790.359 (0.212-0.609)\<.0010.357 (0.191-0.667)**.001**Postoperative SSI0.260.620.416 (0.140-1.241).1160.225 (0.071-0.714)**.011**Postoperative PE0.270.930.293 (0.116-0.741).0090.280 (0.102-0.769)**.014**Postoperative DVT0.210.620.343 (0.112-1.044).0600.348 (0.096-1.264).109Postoperative bleeding requiring transfusion1.6014.550.095 (0.071-0.128)\<.0010.197 (0.137-0.282)**\<.001**Postoperative pneumonia0.410.930.440 (0.181-1.070).0701.257 (0.366-4.312).717Postoperative renal insufficiency0.080.310.245 (0.047-1.267).0930.449 (0.059-3.427).440Postoperative cardiac arrest0.060.310.393 (0.044-3.521).4041.898 (0.072-50.024).701Postoperative myocardial infarction0.170.620.269 (0.085-0.848).0250.732 (0.151-3.545).698Postoperative urinary tract infection0.521.860.275 (0.142-0.533)\<.0010.764 (0.299-1.954).575[^9][^10]Table VIBivariate and multivariate analysis of postoperative complications between CA and fractureCAFractureBivariate analysisMultivariate analysis(n = 725), %(n = 646), %Odds ratio*P* valueOdds ratio*P* valueReadmission3.596.810.509 (0.309-0.836).0080.615 (0.357-1.061).081Postoperative dislocation0.552.010.270 (0.088-0.833).0230.259 (0.078-0.857)**.027**Nonroutine discharge11.3135.450.226 (0.170-0.300)\<.0010.394 (0.285-0.544)**\<.001**Return to OR1.382.790.488 (0.224-1.065).0720.490 (0.211-1.137).097Postoperative SSI0.830.621.339 (0.376-4.767).6520.832 (0.224-3.086).783Postoperative PE0.550.930.592 (0.166-2.106).4180.529 (0.141-1.987).345Postoperative DVT0.970.621.565 (0.456-5.370).4771.576 (0.396-6.272).519Postoperative bleeding requiring transfusion2.3414.550.141 (0.083-0.239)\<.0010.253 (0.144-0.447)**\<.001**Postoperative pneumonia0.550.930.592 (0.166-2.106).4181.573 (0.348-7.112).556Postoperative renal insufficiency0.140.310.445 (0.040-4.916).5090.647 (0.045-9.330).647Postoperative cardiac arrest0.140.31N/A.992N/A.992Postoperative myocardial infarction0.410.620.667 (0.149-2.991).5971.490 (0.238-9.309).670Postoperative urinary tract infection0.551.860.293 (0.094-0.913).0340.718 (0.195-2.642).619[^11][^12]Table VIIBivariate and multivariate analysis of postoperative complications between OA/CA and revisionOA/CARevisionBivariate analysisMultivariate analysis(n = 7295), %(n = 673), %Odds ratio*P* valueOdds ratio*P* valueReadmission2.485.050.480 (0.330-0.699)\<.0010.512 (0.347-0.756)**.001**Postoperative dislocation0.472.530.181 (0.100-0.325)\<.0010.188 (0.103-0.342)**\<.001**Nonroutine discharge9.4010.400.883 (0.681-1.145).3460.943 (0.712-1.249).682Return to OR1.063.710.277 (0.175-0.437)\<.0010.306 (0.190-0.492)**\<.001**Postoperative SSI0.322.530.122 (0.065-0.230)\<.0010.132 (0.068-0.255)**\<.001**Postoperative PE0.300.590.506 (0.174-1.472).2110.438 (0.149-1.283).132Postoperative DVT0.291.040.321 (0.129-0.798).0140.311 (0.124-0.783)**.013**Postoperative bleeding requiring transfusion1.675.500.292 (0.201-0.426)\<.0010.318 (0.216-0.469)**\<.001**Postoperative pneumonia0.420.450.953 (0.291-3.126).9371.051 (0.310-3.563).936Postoperative renal insufficiency0.080.00N/A.992N/A.992Postoperative cardiac arrest0.050.00N/A.992N/A.992Postoperative myocardial infarction0.190.151.292 (0.170-9.841).8051.460 (0.187-11.386).718Postoperative urinary tract infection0.521.04N/A.992N/A.992[^13][^14]Table VIIIBivariate and multivariate analysis of postoperative complications between fracture and revisionFractureRevisionBivariate analysisMultivariate analysis(n = 646), %(n = 673), %Odds ratio*P* valueOdds ratio*P* valueReadmission6.815.051.378 (0.869-2.186).1731.196 (0.723-1.979).486Postoperative dislocation2.012.530.792 (0.382-1.645).5330.936 (0.423-2.071).871Nonroutine discharge35.4510.404.731 (3.521-6.356)\<.0012.351 (1.687-3.278)**\<.001**Return to OR2.793.710.743 (0.401-1.375).3440.787 (0.400-1.548).488Postoperative SSI0.622.530.240 (0.080-0.718).0110.492 (0.159-1.523).218Postoperative PE0.930.591.568 (0.440-5.582).4881.371 (0.369-5.091).637Postoperative DVT0.621.040.693 (0.195-2.466).5710.510 (0.118-2.207).367Postoperative bleeding requiring transfusion14.555.502.927 (1.968-4.353)\<.0011.542 (1.150-2.380)**.045**Postoperative pneumonia0.930.452.094 (0.521-8.407).2970.752 (0.166-3.410).712Postoperative renal insufficiency0.310.00N/A.992N/A.992Postoperative cardiac arrest0.310.00N/A.992N/A.992Postoperative myocardial infarction0.620.154.187 (0.467-37.560).2011.787 (0.175-18.210).624Postoperative urinary tract infection1.861.04N/A.992N/A.992[^15][^16]

Among patients undergoing revision TSA, the most common reason for revision was prosthetic loosening (31.95%), followed by dislocation (12.78%) and infection, fracture, and rotator cuff disease (5.94%). Patients who underwent revision TSA for a primary diagnosis of infection were more likely to experience postoperative SSI (*P* \< .001), whereas those undergoing revision with a primary diagnosis of dislocation were at a greater risk for postoperative DVT (*P* = .018; [Table IX](#tbl9){ref-type="table"}).Table IXComparison of etiologic factors for revision as independent risk factors for adverse outcomesOnly revision surgery patientsIndependent risk factors for adverse outcomesReadmissionPostoperative dislocationPostoperative SSIPostoperative DVTNonhome dischargeEtiologic factor for revision (n = 673)Odds ratio*P* valueOdds ratio*P* valueOdds ratio*P* valueOdds ratio*P* valueOdds ratio*P* valueDislocation (12.78%)0.648 (0.194-2.168).4820.908 (0.204-4.041).8990.908 (0.204-4.041).8997.036 (1.397-35.438)**.018**1.479 (0.759-2.883).250Loosening (31.95%)1.020 (0.488-2.132).9580.449 (0.128-1.578).2120.885 (0.308-2.544).8210.423 (0.049-3.646).4340.837 (0.485-1.445).523Infection (5.94%)2.233 (0.746-6.683).1510.000.9987.393 (2.467-22.152)**\<.001**0.000.9980.955 (0.329-2.766).932Fracture (5.94%)0.988 (0.228-4.281).9880.989 (0.128-7.650).9910.000.9983.221 (0.367-28.242).2911.919 (0.815-4.518).136Stiffness (0.59%)0.000.9990.000.9990.000.9990.000.9990.000.999Rotator cuff disease (5.94%)1.575 (0.460-5.391).4700.989 (0.128-7.650).9910.000.9980.000.9991.248 (0.472-3.298).655Pain (5.05%)1.186 (0.272-5.167).8211.180 (0.152-9.169).8740.000.9980.000.9980.525 (0.123-2.239).384Other (31.79%)[^17][^18]

In comparing only patients who were unexpectedly readmitted within 30 days of surgery, revision patients were at a greater risk for readmission for infection compared with OA and CA (*P* = .012) and fracture patients (*P* = .008; [Table X](#tbl10){ref-type="table"}). Among readmissions, CA patients were more likely to experience readmission for cardiac complications compared with OA patients (*P* = .028).Table XBivariate analysis and associated *P* values of reason for readmission among surgical groupsReason for readmissionOAFractureBivariate analysis(n = 155), %(n = 44), %Odds ratio*P* valueDislocation19.3529.550.572 (0.268-1.224).150Infection10.974.552.587 (0.574-11.656).216Bleeding3.232.271.433 (0.163-12.599).745Pain2.584.550.556 (0.098-3.142).507PE or thrombosis7.109.090.764 (0.231-2.528).659Pneumonia10.976.821.684 (0.470-6.031).424Urinary tract infection4.522.272.034 (0.243-16.988).512Cardiac complications3.876.820.550 (0.132-2.296).412CAFracture(n = 26), %(n = 44), %Dislocation15.3829.550.434 (0.125-1.508).189Infection19.234.555.000 (0.894-27.693).067Bleeding11.542.275.609 (0.552-57.022).145Pain3.854.550.840 (0.072-9.744).889PE or thrombosis7.699.090.833 (0.142-4.898).840Pneumonia11.546.821.783 (0.332-9.563).500Urinary tract infection0.002.27N/A.998Cardiac complications15.386.822.485 (0.510-12.113).260CAOA(n = 26), %(n = 155), %Dislocation15.3819.350.758 (0.243-2.363).632Infection19.2310.971.933 (0.645-5.793).239Bleeding11.543.233.913 (0.876-17.487).074Pain3.852.581.510 (0.162-14.068).717PE or thrombosis7.697.101.091 (0.228-5.230).913Pneumonia11.5410.971.059 (0.287-3.902).932Urinary tract infection0.004.52N/A.998Cardiac complications15.383.874.515 (1.180-17.278)**.028**OA/CARevision(n = 181), %(n = 28), %Dislocation18.7825.000.642 (0.275-1.501).307Infection12.1532.140.332 (0.140-0.786)**.012**Bleeding4.420.00N/A.998Pain2.760.00N/A.998PE or thrombosis7.183.572.554 (0.323-20.194).374Pneumonia11.053.574.099 (0.531-31.621).176Urinary tract infection3.870.00N/A.998Cardiac complications5.5210.710.604 (0.157-2.321).463FractureRevision(n = 44), %(n = 28), %Dislocation29.5525.001.165 (0.429-3.166).765Infection4.5532.140.114 (0.023-0.565)**.008**Bleeding2.270.00N/A.998Pain4.550.00N/A.998PE or thrombosis9.093.573.300 (0.352-30.975).296Pneumonia6.823.572.415 (0.240-24.305).454Urinary tract infection2.270.00N/A.998Cardiac complications6.8210.710.756 (0.143-4.004).742FractureOA/CA(n = 44), %(n = 181), %Dislocation29.5518.781.813 (0.859-3.828).119Infection4.5512.150.344 (0.078-1.522).160Bleeding2.274.420.503 (0.061-4.130).522Pain4.552.761.676 (0.314-8.940).545PE or thrombosis9.097.181.292 (0.400-4.174).668Pneumonia6.8211.050.589 (0.167-2.079).411Urinary tract infection2.273.870.578 (0.069-4.824).613Cardiac complications6.825.521.251 (0.329-4.752).742[^19][^20]

Time from operation to discharge was 1.75 days in OA, 1.88 days in CA, 2.66 days in fracture, and 2.04 days in revision ([Fig. 1](#fig1){ref-type="fig"}). Mean differences in discharge time were statistically significant between fracture and all other surgical indications (*P* \< .001). Revision patients had a longer time to discharge compared with OA patients (*P* \< .001).Figure 1(**A**) Comparison of time from operation to discharge among surgical groups using univariate analysis of variance with Tukey test. (**B**) Comparison of mean time from operation to discharge among surgical indication groups. *OA*, osteoarthritis; *CA*, cuff arthropathy.

Discussion {#sec3}
==========

As the landscape of health care economics shifts toward bundled outcomes-based reimbursements, providers must be aware of the differences in TSA postoperative outcomes to be expected between various evolving surgical indications. Patient demographics and associated risk factors are unique to each surgical indication group and affect the recovery process differently.[@bib5] Understanding the risks of adverse outcomes, such as DVT and SSI, is important in our population of aging patients with multiple comorbidities and is the initial step in being able to achieve cost-effectiveness and better use of resources.[@bib25]

In comparing baseline characteristics between OA, CA, fracture, and revision, surgeons can better inform patients in the consent process and plan for interdisciplinary medical optimization of fracture patients, who are typically older, have a higher ASA class, and are more likely to have diabetes compared with OA and CA patients. The higher percentage of female patients in the fracture group and longer average operative times compared with OA and CA are characteristics that are likely to reflect poor bone stock and surgical technical difficulties of which the surgeon should be aware in predicting future clinical outcomes.[@bib37] Whereas there is limited and conflicting literature comparing hemiarthroplasty, internal fixation, and TSA for proximal humerus fractures, our findings of high percentages of ASA class ≥3, diabetics, and long operative times indicate the importance of counseling fracture patients that short-term TSA complications may reflect comorbidity rather than procedural outcomes.[@bib7] The high rates of smoking and younger age of revision patients must be considered in planning for postoperative rehabilitation protocols as smoking has been linked to prosthetic loosening, wound infections, and increased risk for further revision.[@bib34], [@bib36] The younger age of revision patients in this study is consistent with other studies that found increased risk of revision and primary arthroplasty failure in younger patients.[@bib12], [@bib14], [@bib34], [@bib36] Although the etiology is still unclear, the increased activity level and complex pathologic process, such as inflammatory arthritis, post-traumatic arthropathy, or capsulorrhaphy arthropathy, seen in younger patients are thought to contribute to increased implant failure rates compared with the elderly.[@bib12], [@bib34] Previous reports have found revision arthroplasty outcomes inferior to outcomes after primary shoulder arthroplasty due to soft tissue injury, and this study warrants further discussion and education between the surgeon and young arthroplasty patients about careful postoperative rehabilitation and medical optimization.[@bib3], [@bib4], [@bib32]

Whereas the long-term functional improvements and reoperation rates in CA patients after RTSA remain unclear, there have been no comparisons of short-term complications between OA and CA patients despite the fact that OA and CA represent a majority of arthroplasty indications.[@bib19] Previous reports have found CA associated with pseudoparalysis, anterosuperior escape, and comorbid conditions such as cervical radiculopathy to correlate with poor functional improvements.[@bib21] The greater risk of DVT and SSI in CA patients compared with OA patients should be considered for modifications to the postoperative rehabilitation protocol as patients are more likely to report index procedure dissatisfaction with unexpected inability to return to daily functioning.[@bib30] Although studies have shown CA to be a risk factor for revision surgery and failure to achieve American Shoulder and Elbow Surgeons minimal clinically important difference compared with OA, this study further expands the need to consider DVT and SSI in evaluating outcomes-based care. Guidelines for perioperative mechanical or chemical prophylaxis for thrombosis after shoulder arthroplasty have not been established but are important in preventing unexpected prolonged hospital stays and revisions.[@bib1] These unexpected outcomes are especially important to consider in fracture patients, who require extensive interdisciplinary postoperative care because of increased risk for readmission, postoperative dislocation, nonroutine discharge, return to the OR, SSI, PE, and postoperative bleeding requiring transfusion. Increased risk of nonroutine discharge, blood loss, and return to the OR compared with OA and CA suggest poorer return to independent mobility and activities of daily living with increased hospitalization costs.[@bib17]

Previous studies have found revision arthroplasty groups to have worse functional outcomes and greater risk for postoperative complications compared with primary arthroplasty.[@bib3], [@bib6], [@bib10], [@bib11], [@bib32] In our study, revision patients were at a greater risk for readmission, postoperative dislocation, return to the OR, SSI, DVT, and postoperative bleeding requiring transfusion compared with primary OA and CA patients. Prior soft tissue mobilization and rotator cuff manipulation are thought to affect prosthetic implant stabilization and may play a role in the increased dislocation, infection, and bleeding rates seen in revision patients.[@bib28] Among revision patients, TSA for prior dislocation is a risk factor for postoperative DVT as implant stabilization must be carefully balanced with early return to activity. Dislocation, loosening, instability, and infection are common revision causes that may be due to the increased rate of *Cutibacterium* (formerly *Propionibacterium*) *acnes* colonization of the shoulder and implant.[@bib29] Among revision patients, infection as an etiologic factor was significantly associated with increased postoperative SSI, highlighting the importance of careful intraoperative and postoperative measures to prevent reoperation and site bleeding.

RTSA has become an increasingly popular option for treating proximal humerus fractures in the elderly as the need for cuff integrity and anatomic tuberosity healing is minimized.[@bib18] However, short-term adverse outcomes are important to consider in this older, female population with inherent risks of anesthesia because compromised vascularity and poor bone quality may necessitate revision surgery.[@bib13] Whereas treatment of proximal humerus fractures varies between conservative management, hemiarthroplasty, and TSA, the increased risk of nonroutine discharge compared with revision patients predicts poorer return to independent mobility and increased costs that should be balanced with lifestyle considerations. In this study, fracture patients are at an increased risk of postoperative bleeding requiring transfusion, which is consistent with prior reports of hematoma and instability after arthroplasty.[@bib2] Time from operation to discharge in fracture patients is significantly longer compared with the other surgical groups, and these associated increased hospitalization costs should be recognized and made clear to patients during preoperative planning.

There are limitations to be considered in using the NSQIP database despite the large number of patients and variables included. Complication rates are limited to 30-day outcomes, and although the use of RTSA is becoming more prevalent, CPT code 23472 was not able to separate reverse from anatomic arthroplasty. However, previous studies have found both anatomic TSA and RTSA to have similar complication rates, revision rates, and patient-reported outcomes, and this study focuses on short 30-day hospital quality metrics.[@bib15], [@bib23], [@bib33]

Conclusions {#sec4}
===========

Overall, this study provides evidence that surgical indication is an independent risk predictor for postoperative readmission, dislocation, nonroutine discharge, postoperative outcomes, and increased time to discharge. Understanding of surgical risk factors is important not only for managing patients\' expectations but also for identifying indications that predict costly complications and adverse outcomes. With new outcomes-based reimbursement models, nonroutine discharge and increased discharge time in proximal humerus fracture patients should be considered in arthroplasty planning.
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[^1]: *OA*, osteoarthritis; *CA*, cuff arthropathy; *BMI*, body mass index; *ASA*, American Society of Anesthesiologists.

[^2]: Categorical variables are presented as percentage.

[^3]: *OA*, osteoarthritis; *CA*, cuff arthropathy; *BMI*, body mass index; *ASA*, American Society of Anesthesiologists.

[^4]: Significant differences (*P* \< .05) are indicated with bold text.

[^5]: *OA*, osteoarthritis; *CA*, cuff arthropathy; *OR*, operating room; *SSI*, surgical site infection; *PE*, pulmonary embolism; *DVT*, deep venous thrombosis; *N/A*, not applicable.

[^6]: Significant differences (*P* \< .05) are indicated with bold text.

[^7]: *OA*, osteoarthritis; *CA*, cuff arthropathy; *OR*, operating room; *SSI*, surgical site infection; *PE*, pulmonary embolism; *DVT*, deep venous thrombosis.

[^8]: Significant differences (*P* \< .05) are indicated with bold text.

[^9]: *OA*, osteoarthritis; *OR*, operating room; *SSI*, surgical site infection; *PE*, pulmonary embolism; *DVT*, deep venous thrombosis.

[^10]: Significant differences (*P* \< .05) are indicated with bold text.

[^11]: *CA*, cuff arthropathy; *OR*, operating room; *SSI*, surgical site infection; *PE*, pulmonary embolism; *DVT*, deep venous thrombosis; *N/A*, not applicable.

[^12]: Significant differences (*P* \< .05) are indicated with bold text.

[^13]: *OA*, osteoarthritis; *CA*, cuff arthropathy; *OR*, operating room; *SSI*, surgical site infection; *PE*, pulmonary embolism; *DVT*, deep venous thrombosis; *N/A*, not applicable.

[^14]: Significant differences (*P* \< .05) are indicated with bold text.

[^15]: *OR*, operating room; *SSI*, surgical site infection; *PE*, pulmonary embolism; *DVT*, deep venous thrombosis; *N/A*, not applicable.

[^16]: Significant differences (*P* \< .05) are indicated with bold text.

[^17]: *SSI*, surgical site infection; *DVT*, deep venous thrombosis.

[^18]: Significant differences (*P* \< .05) are indicated with bold text.

[^19]: *OA*, osteoarthritis; *PE*, pulmonary embolism; *CA*, cuff arthropathy; *N/A*, not applicable.

[^20]: Significant differences (*P* \< .05) are indicated with bold text.
